- Home
- LNTH vs PAM Comparison
LNTH vs PAM Comparison
Compare LNTH & PAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | PAM |
|---|---|---|
| Founded | 1956 | 1945 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 5.0B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | PAM |
|---|---|---|
| Price | $63.42 | $90.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | $74.17 | ★ $92.75 |
| AVG Volume (30 Days) | ★ 1.1M | 225.0K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.39 | 0.24 |
| Revenue | $1,525,933,000.00 | ★ $1,926,000,000.00 |
| Revenue This Year | $0.01 | $136,919.08 |
| Revenue Next Year | $1.24 | $36.38 |
| P/E Ratio | $26.45 | ★ $15.77 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $47.25 | $54.95 |
| 52 Week High | $111.29 | $97.55 |
Technical Indicators
Market Signals| Indicator | LNTH | PAM |
|---|---|---|
| Relative Strength Index (RSI) | 71.16 | 62.42 |
| Support Level | $57.44 | $89.01 |
| Resistance Level | $59.30 | $91.02 |
| Average True Range (ATR) | 2.14 | 3.52 |
| MACD | 0.82 | -0.46 |
| Stochastic Oscillator | 91.35 | 66.81 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About PAM Pampa Energia S.A.
Pampa Energia SA and its subsidiaries are engaged in the Energy business, mainly in oil and gas production and power generation. The firm's operating business segments are Oil and Gas, Generation, Petrochemicals, Holding, Transportation, and Others. The company derives the maximum revenue from the oil and gas segment.